Cytori Therapeutics (CYTX) Misses Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q2 EPS of ($0.59), $0.14 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Everus Construction Group acquires Epsilon Industries for $295M
- California Resources completes $63M acquisition of Crimson Midstream
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
